Bioreductively activated lysyl oxidase inhibitors against hypoxic tumours.
about
Lysyl oxidase: a lung adenocarcinoma biomarker of invasion and survivalTargeting lysyl oxidase for molecular imaging in breast cancer.Lysyl oxidase: a potential target for cancer therapy.Design, synthesis and evaluation of molecularly targeted hypoxia-activated prodrugs.CH-01 is a hypoxia-activated prodrug that sensitizes cells to hypoxia/reoxygenation through inhibition of Chk1 and Aurora A.Evaluation of Fluorine-18-Labeled α1(I)-N-Telopeptide Analogs as Substrate-Based Radiotracers for PET Imaging of Melanoma-Associated Lysyl Oxidase.
P2860
Bioreductively activated lysyl oxidase inhibitors against hypoxic tumours.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Bioreductively activated lysyl oxidase inhibitors against hypoxic tumours.
@en
Bioreductively activated lysyl oxidase inhibitors against hypoxic tumours.
@nl
type
label
Bioreductively activated lysyl oxidase inhibitors against hypoxic tumours.
@en
Bioreductively activated lysyl oxidase inhibitors against hypoxic tumours.
@nl
prefLabel
Bioreductively activated lysyl oxidase inhibitors against hypoxic tumours.
@en
Bioreductively activated lysyl oxidase inhibitors against hypoxic tumours.
@nl
P2093
P2860
P50
P356
P1433
P1476
Bioreductively activated lysyl oxidase inhibitors against hypoxic tumours.
@en
P2093
Amato J Giaccia
Marco Macchia
Tiziana Funaioli
P2860
P304
P356
10.1002/CMDC.200900247
P577
2009-10-01T00:00:00Z